Cargando…

Corrigendum: Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy

Detalles Bibliográficos
Autores principales:	Ding, Zhi-Ming, Xiao, Yue, Wu, Xikun, Zou, Haixia, Yang, Shurong, Shen, Yiyun, Xu, Juehua, Workman, Heather C., Usborne, Amy L., Hua, Haiqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042384/ https://www.ncbi.nlm.nih.gov/pubmed/32140108 http://dx.doi.org/10.3389/fphar.2020.00093

Ejemplares similares

Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy
por: Ding, Zhi-Ming, et al.
Publicado: (2018)

Evolving Role for Pharmacotherapy in NAFLD/NASH
por: Attia, Suzanna L., et al.
Publicado: (2020)

Pharmacotherapy for Fibromyalgia
por: Smith, Howard S., et al.
Publicado: (2011)

Challenges in the Pharmacotherapy of Urogenital Disorders
por: Michel, Martin C.
Publicado: (2010)

Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy
por: Wang, Yan-Ni, et al.
Publicado: (2022)

Sleep Related Epilepsy and Pharmacotherapy: An Insight
por: Kumar, Jaya, et al.
Publicado: (2018)

Pharmacotherapy for Behçet’s Disease and the Risk of Malignancy
por: Huang, Mao-Xin, et al.
Publicado: (2021)

Consistency of recommendations for pharmacotherapy of rheumatoid arthritis
por: Hu, Yue, et al.
Publicado: (2022)

Toward a Personalized Pharmacotherapy of Respiratory Diseases
por: Montuschi, Paolo
Publicado: (2010)

The Pathogenesis of HCC Driven by NASH and the Preventive and Therapeutic Effects of Natural Products
por: Shao, Gaoxuan, et al.
Publicado: (2022)

Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy?
por: Roco, Ángela, et al.
Publicado: (2014)

Editorial: New Trends and Approaches in Perioperative Pharmacotherapy: An Update
por: Soghomonyan, S., et al.
Publicado: (2021)

Future Pharmacotherapy for Non-alcoholic Steatohepatitis (NASH): Review of Phase 2 and 3 Trials
por: Connolly, James J., et al.
Publicado: (2018)

Corrigendum: TAZ induces migration of microglia and promotes neurological recovery after spinal cord injury
por: Hu, Xuyang, et al.
Publicado: (2022)

Pharmacotherapy of mild cognitive impairment
por: Gauthier, Serge
Publicado: (2004)

Pharmacotherapy of Patients with Mild Persistent Asthma: Strategies and Unresolved Issues
por: Montuschi, Paolo
Publicado: (2011)

Pharmacotherapy of Alzheimer’s Disease: Seeking Clarity in a Time of Uncertainty
por: Husna Ibrahim, Nurul, et al.
Publicado: (2020)

Pharmacotherapy of Lower Respiratory Tract Infections in Elderly—Focused on Antibiotics
por: Liu, Yang, et al.
Publicado: (2019)

Molecular Mechanisms and Current Pharmacotherapy of Peyronie’s Disease: A Review
por: Zhang, Fuxun, et al.
Publicado: (2021)

Ileal Bile Acid Transporter Inhibition for the Treatment of Chronic Constipation, Cholestatic Pruritus, and NASH
por: Al-Dury, Samer, et al.
Publicado: (2018)

Lysophosphatidic acid receptor 1 antagonist (EPGN2154) causes regression of NASH in preclinical NASH models
por: Bhattacharjee, Jashdeep, et al.
Publicado: (2023)

Corrigendum: Circadian Pharmacological Effects of Paeoniflorin on Mice With Urticaria-like Lesions
por: Peng, Li, et al.
Publicado: (2022)

Pharmacotherapy for anxiety disorders in children and adolescents
por: Kodish, Ian, et al.
Publicado: (2011)

Grand Challenges in Pharmacotherapy of Inflammation for the First Decades of the 21st Century
por: Patrignani, Paola, et al.
Publicado: (2010)

Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia: State of the Art and Future Progress
por: Magierski, Radoslaw, et al.
Publicado: (2020)

Gender Differences in Cardiovascular Pharmacotherapy—the Example of Hypertension: A Mini Review
por: Kalibala, Jacklean, et al.
Publicado: (2020)

Editorial: From Trial and Error to Individualised Pharmacogenomics-Based Pharmacotherapy in Psychiatry
por: van Westrhenen, R., et al.
Publicado: (2021)

Pharmacotherapies for Drug-Induced Liver Injury: A Current Literature Review
por: Li, Meng, et al.
Publicado: (2022)

NMDAR in bladder smooth muscle is not a pharmacotherapy target for overactive bladder in mice
por: Xie, Xiang, et al.
Publicado: (2021)

Pharmacotherapy of anxiety disorders: a critical review
por: Koen, Nastassja, et al.
Publicado: (2011)

Evaluation of the efficacy of mitochondrial fission inhibitor (Mdivi-1) using non-alcoholic steatohepatitis (NASH) liver organoids
por: Elbadawy, Mohamed, et al.
Publicado: (2023)

Editorial: The pharmacotherapy of depression—searching for new mechanisms and drug interactions basic and clinical research
por: Stachowicz, Katarzyna, et al.
Publicado: (2022)

Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review
por: Roberts, Bradley, et al.
Publicado: (2023)

Deciphering the Effective Constituents and Mechanisms of Portulaca oleracea L. for Treating NASH via Integrating Bioinformatics Analysis and Experimental Pharmacology
por: He, Xiaoli, et al.
Publicado: (2022)

Pharmacotherapy of Traumatic Childhood Aphasia: Beneficial Effects of Donepezil Alone and Combined With Intensive Naming Therapy
por: Dávila, Guadalupe, et al.
Publicado: (2020)

Information and Communication Technologies, a Promising Way to Support Pharmacotherapy for the Behavioral and Psychological Symptoms of Dementia
por: Piau, Antoine, et al.
Publicado: (2019)

Sleep and the Pharmacotherapy of Alcohol Use Disorder: Unfortunate Bedfellows. A Systematic Review With Meta-Analysis
por: Panin, Francesca, et al.
Publicado: (2019)

Comparative efficacy and acceptability of pharmacotherapies for postpartum depression: A systematic review and network meta-analysis
por: Zhang, Qing, et al.
Publicado: (2022)

Co-micronized Palmitoylethanolamide/Polydatin Treatment Causes Endometriotic Lesion Regression in a Rodent Model of Surgically Induced Endometriosis
por: Di Paola, Rosanna, et al.
Publicado: (2016)

Corrigendum: The Role of High-Content Complex Dietary Fiber in Medical Nutrition Therapy for Gestational Diabetes Mellitus
por: Wang, Hong-Kun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ibm5hpb078foslfnvp9oncq4p5